Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro

Cancer Letters

Volumn 216, Issue 1, 2004, Pages 9-20

  Lu, Qing Yi ^a   Jin, Yu Sheng ^a   Zhang, Qifeng ^a   Zhang, Zuofeng ^b   Heber, David ^a   Go, Vay Liang W ^a   Li, Frederick P ^c   Rao, Jian Yu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Actin polymerization; Bladder cancer; Chemoprevention; Ganoderma lucidum

Indexed keywords

4 BIPHENYLAMINE; ACTIN; ALCOHOL; CARCINOGEN; FOCAL ADHESION KINASE; GANODERMA LUCIDUM EXTRACT; GELATINASE A; WATER;

ACTIN POLYMERIZATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL LINE; CELL MIGRATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; FOCAL ADHESION; GANODERMA LUCIDUM; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS FIBER; UROTHELIUM;

ACTINS; CELL ADHESION; CELL CYCLE; CHEMOPREVENTION; DRUGS, CHINESE HERBAL; HUMANS; REISHI; SPORES; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

GANODERMA; GANODERMA LUCIDUM;

EID: 6944238974     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.022     Document Type: Article

References (41)

1. Z.B. Lin Pharmacological functions of Ganoderma lucidum Z.B. Lin second ed. Modern Research of Ganoderma lucidum 2001 Beijing Medical University Press Beijing 284 309
2. S.P. Wasser, and A.L. Weis Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspective Int. J. Med. Mushrooms 1 1999 31 62
3. M.S. Shiao Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions Chem. Rec. 3 2003 172 180
4. W.H. Yeung, Q.Y. Lu, and Q. Zhang VLW Go Chemical and Biochemical basis of the potential anti-tumor properties of Ganoderma lucidum Curr. Top. Nutraceutical Res. 2 2004 67 77
5. H. Hu, N.S. Ahn, X. Yang, Y.S. Lee, and K.S. Kang Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell Int. J. Cancer 102 2002 250 253
6. D. Sliva, C. Labarrere, V. Slivova, M. Sedlak, F.P. Lloyd Jr., and N.W. Ho Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells Biochem. Biophys. Res. Commun. 298 2002 603 612
7. M.A. Ghafar, E. Golliday, J. Bingham, M.M. Mansukhani, A.G. Anastasiadis, and A.E. Katz Regression of prostate cancer following administration of genistein combined polysaccharide (GCP™), a nutritional supplement: a case report J. Altern. Complement. Med. 8 2002 493 497
8. Y. Gao, S. Zhou, W. Jiang, M. Huang, and X. Dai Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients Immunol. Invest. 32 2003 201 215
9. Y.S. Song, S.H. Kim, J.H. Sa, C. Jin, C.J. Lim, and E.H. Park Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum J Ethnopharmacol. 90 2004 17 20
10. B. Lakshmi, T.A. Ajith, N. Sheena, N. Gunapalan, and K.K. Janardhanan Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India Teratog Carcinog Mutagen 1 suppl 2003 85 97
11. E.A. Bookland, S. Swaminathan, R. Oyasu, K.W. Gilchrist, M. Lindstrom, and C.A. Reznikoff Tumorigenic transformation and neoplastic progression of human uroepithelial cells after exposure in vitro to 4-aminobiphenyl or its metabolites Cancer Res. 52 1992 1606 1614
12. J.Y. Rao, R.B. Bonner, R.E. Hurst, Y.Y. Liang, C.A. Reznikoff, and G.P. Hemstreet Quantitative changes in cytoskeletal and nuclear actins during cellular transformation Int. J. Cancer 70 1997 423 429
13. J.Y. Rao, R.E. Hurst, W.D. Bales, P.L. Jones, R.A. Bass, and L.T. Archer Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation Cancer Res. 50 1990 2215 2220
14. J.Y. Rao, G.P. Hemstreet, R.E. Hurst, R.B. Bonner, K.W. Min, and P.L. Jones Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk Cancer Res. 51 1991 2762 2767
15. J.Y. Rao, G.P. Hemstreet, R.E. Hurst, R.B. Bonner, P.L. Jones, K.W. Min, and Y. Fradet Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis Proc. Natl Acad. Sci. USA 90 1993 8287 8291
16. H. Kanayama Matrix metalloproteinases and bladder cancer J. Med. Invest. 48 2001 31 43
17. B.S. Min, J.J. Gao, N. Nakamura, and M. Hattori Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells Chem. Pharm. Bull. 48 2000 1026 1033
18. H.S. Zhu, X.L. Yang, L.B. Wang, D.X. Zhao, and L. Chen Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells Cell Biol. Toxicol. 16 2000 201 206
19. S. Lee, S. Park, J.W. Oh, and C. Yang Natural inhibitors for protein prenyltransferase Planta Medica 64 1998 303 308
20. T. Ikekawa, M. Nakanishi, N. Uehara, G. Chihara, and F. Fukuoka Antitumor action of some Basidiomycetes, especially Phllinus inteus Gann 59 1968 155 157
21. H. Ito, S. Naruse, and K. Shimura Studies on antitumor activity of basidiomycete polysaccharides: VII. Antitumor effect of the polysaccharide preparations from Ganoderma lucidum on mouse sarcoma 180 Mie Med. J. 26 1977 147 152
22. T. Miyazaki, and M. Nishijima Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum Chem. Pharm. Bull. 29 1981 3611 3616
23. M. Miyazaki, and M. Nishijima Structural examination of an alkali-extracted, water-soluble heteroglycan of the fungus Ganoderma lucidum Carb. Res. 109 1982 290 294
24. S. Ukai, S. Yokoyam, H. Chihiro, and T. Kiho Structure of an alkali-soluble polysaccharide from the fruit body of Ganoderma japonicum Lloyd Carb. Res. 105 1982 237 245
25. T. Usui, Y. Iwasaki, T. Mizuno, M. Tanaka, N. Shinkai, and M. Arakawa Isolation and characterization of antitumor active d-glucans from the fruit bodies of Ganoderma applanatum Carb. Res. 115 1983 273 280
26. H. Maruyama, K. Yamazaki, S. Murotushi, C. Konda, and T. Ikekawa Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst J. Pharmacobiodyn. 12 1989 118 123
27. T.W. Chen, Y.K. Wong, and S.S. Lee In vitro cytotoxicity of Ganoderma lucidum on oral cancer cells Chin. Med. J. 48 1991 54 58
28. X.F. Bao, C.P. Liu, J.N. Fang, and X.Y. Li Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst Carb. Res. 332 2001 67 74
29. X.F. Bao, Y. Zhen, L. Ruan, and J.N. Fang Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum Chem. Pharm. Bull. 50 2002 623 629
30. E. Furusawa, S.C. Chou, S. Furusawa, A. Hirazumi, and Y. Dang Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice Phytother. Res. 6 1992 300 304
31. C.W. Lieu, S.S. Lee, and S.Y. Wang The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells Anticancer Res. 12 1992 1211 1216
32. S.Y. Wang, M.L. Hsu, H.C. Hsu, C.H. Tzeng, S.S. Lee, M.S. Shiao, and C.K. Ho The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes Int. J. Cancer 70 1997 699 705
33. L. Zhong, D. Jiang, and Q.J. Wang Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells Hunan Yi Ke Da Xue Xue Bao 24 1999 521 524
34. J. Kassis, D.A. Lauffenburger, T. Turner, and A. Wells Tumor invasion as dysregulated cell motility Semin. Cancer Biol. 11 2001 105 117
35. E.M. Messing, P. Hanson, and C.A. Reznikoff Normal and malignant human urothelium: in vitro response to blockade of polyamine synthesis and interconversion Cancer Res. 48 1988 357 561
36. J.T. Price, M.T. Bonovich, and E.C. Kohn The biochemistry of cancer dissemination Crit. Rev. Biochem. Mol. Biol. 32 1997 175 253
37. K.Y. Han, A.J. Pantuck, A.S. Belldegrun, and J.Y. Rao Tumor markers for the early detection of bladder cancer Front. Biosci. 7 2002 e19 e26
38. M.R. Bubb, A.M. Senderowicz, E.A. Sausville, K.L. Duncan, and E.D. Korn Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin J. Biol. Chem. 269 1994 14869 14871
39. A.M. Senderowicz, G. Kaur, E. Sainz, C. Laing, W.D. Inman, and J. Rodriguez Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton J. Natl Cancer Inst. 87 1995 46 51
40. M.D. Duncan, J.W. Harmon, and L.K. Duncan Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells Biochem. Pharmacol. 52 1996 1553 1560
41. G.P. Hemstreet, J.Y. Rao, R.E. Hurst, R.B. Bonner, J.E. Mellott, and G.M. Rooker Biomarkers in monitoring the effectiveness of chemopreventive and immunotherapeutic treatments of bladder cancer with dimethylsulfoxide Cancer Detect. Prev. 23 1999 163 171